Trabectedin for recurrent grade 2 or 3 meningiomas

Neuro-Oncology: The Podcast

English - January 28, 2022 14:22 - 17 minutes - 15.7 MB - ★★★★★ - 9 ratings
Medicine Health & Fitness Science Life Sciences brain oncology tumors glioblastoma glioma lymphoma neurology neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Glioblastoma cell heterogeneity and plasticity

Next Episode: The clinical utility of next generation sequencing for IDHwt glioblastoma

Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.